The risk of Wound Healing Complications (WHC) and the early use of mTORi after Kidney Transplantation (KT) have not been fully addressed.
A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early [vs. delayed] introduction of everolimus in de novo kidney transplant recipients, with a follow-up evaluation at 12 month after transplant (NEVERWOUND study)
Secchi, Antonio;
2020-01-01
Abstract
The risk of Wound Healing Complications (WHC) and the early use of mTORi after Kidney Transplantation (KT) have not been fully addressed.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
